Overview

Chemotherapy and Radiation Therapy in Treating Patients With Stage III or Stage IV Head and Neck Cancer

Status:
Completed

Trial end date:
2004-07-03

Target enrollment:

Participant gender:

Summary

Phase I trial to study the effectiveness of docetaxel plus radiation therapy in treating patients who have stage III or stage IV head and neck cancer.

Phase:

Phase 1

Details

Lead Sponsor:

Dana-Farber Cancer Institute

Collaborator:

National Cancer Institute (NCI)

Treatments:

Docetaxel